Filing excerpt
On March 1, 2026, the Company acquired 100% of the outstanding equity of AbMedica, Abex Excelencia Robótica, and their affiliates (collectively, “AbMedica”), a distributor of the Company’s products in certain international markets, for an aggregate purchase price of $528.3 million, net of cash acquired.